Daily weight loss tablet Wegovy cleared by TGA for use in Australia
Te first GLP-1 weight loss tablet has been cleared for use in Australia daily Wegovy tablet has been…
Recall alert: Some GLP-1 injections recalled over sterility concerns – WSB-TV Channel 2
Some vials of compounded GLP-1 injections have been recalled because the products may not be sterile, federal health…
HSE advised to consider public funding for weight-loss jab
THE HSE HAS been advised to consider public funding for semaglutide, the drug marketed as Wegovy, for weight-loss.…
HSE considering reimbursing weight-loss drug Mounjaro – The Irish Times
The HSE is considering reimbursing more weight-loss drugs, known as GLP-1 medications, after receiving a number of applications.…
GLP-1s in Ireland: How weight-loss medications work under the HSE system – The Irish Times
Weight-loss medications such as Ozempic, Wegovy and Mounjaro have become more widely-discussed and available in recent years. But…
HSE to consider public funding for Mounjaro as benefits could be ‘transformative’
A DECISION ON whether to fund the weight-loss drug Mounjaro in Ireland could be “transformative”, according to Prof…
Medicines watchdog receives 24 reports of weight-loss jab side effects related to vision – The Irish Times
There were 24 reports of suspected side effects relating to vision from weight-loss jabs over the past 3½…
NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
Doctors condemn Eli Lilly move to dispense GLP-1 medication Mounjaro direct to door
A move by a multi-billion-dollar global pharmaceutical company to bypass bricks and mortar pharmacies and deliver its GLP-1…
Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision loss
PHOENIX (AZFamily/Gray News) — Hundreds of lawsuits have been filed against major GLP-1 makers Eli Lilly and Novo…
Generic Ozempic, Mounjaro and GLP-1 market in India: why tirzepatide still leads
When cheaper generic versions of semaglutide – originally developed by Danish drugmaker Novo Nordisk and runaway success under…
Kenya reviews Mounjaro market entry
The Pharmacy and Poisons Board (PPB) has begun reviewing an application to register Mounjaro, a booming once-weekly injectable…